OXYGENE MEDICINAL AIR LIQUIDE REUNION 200 bar clinical trials

A Prospective, Open-label Pilot Study to Evaluate Effector Mechanisms of Hyperbaric Oxygen Therapy in Patients with Moderate-to-Severe Ulcerative Colitis: The PARADOX study

This study, called PARADOX, investigates hyperbaric oxygen therapy (HBOT) for moderate-to-severe ulcerative colitis. Researchers want to understand how HBOT works at a very detailed level, looking at blood, gut lining, and gut bacteria to see if it helps reduce inflammation and symptoms.